1
|
Nguyen CP, Maas WJ, van der Zee DJ, Uyttenboogaart M, Buskens E, Lahr MMH. Cost-effectiveness of improvement strategies for reperfusion treatments in acute ischemic stroke: a systematic review. BMC Health Serv Res 2023; 23:315. [PMID: 36998011 PMCID: PMC10064746 DOI: 10.1186/s12913-023-09310-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/15/2022] [Accepted: 03/20/2023] [Indexed: 04/01/2023] Open
Abstract
BACKGROUND Reducing delays along the acute stroke pathway significantly improves clinical outcomes for acute ischemic stroke patients eligible for reperfusion treatments. The economic impact of different strategies reducing onset to treatment (OTT) is crucial information for stakeholders in acute stroke management. This systematic review aimed to provide an overview on the cost-effectiveness of several strategies to reduce OTT. METHODS A comprehensive literature search was conducted in EMBASE, PubMed, and Web of Science until January 2022. Studies were included if they reported 1/ stroke patients treated with intravenous thrombolysis and/or endovascular thrombectomy, 2/ full economic evaluation, and 3/ strategies to reduce OTT. The Consolidated Health Economic Evaluation Reporting Standards statement was applied to assess the reporting quality. RESULTS Twenty studies met the inclusion criteria, of which thirteen were based on cost-utility analysis with the incremental cost-effectiveness ratio per quality-adjusted life year gained as the primary outcome. Studies were performed in twelve countries focusing on four main strategies: educational interventions, organizational models, healthcare delivery infrastructure, and workflow improvements. Sixteen studies showed that the strategies concerning educational interventions, telemedicine between hospitals, mobile stroke units, and workflow improvements, were cost-effective in different settings. The healthcare perspective was predominantly used, and the most common types of models were decision trees, Markov models and simulation models. Overall, fourteen studies were rated as having high reporting quality (79%-94%). CONCLUSIONS A wide range of strategies aimed at reducing OTT is cost-effective in acute stroke care treatment. Existing pathways and local characteristics need to be taken along in assessing proposed improvements.
Collapse
Affiliation(s)
- Chi Phuong Nguyen
- Department of Operations, Faculty of Economics and Business, University of Groningen, Groningen, the Netherlands.
- Department of Epidemiology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.
- Department of Pharmaceutical Administration and Economics, Hanoi University of Pharmacy, Hanoi, Vietnam.
| | - Willemijn J Maas
- Department of Epidemiology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands
- Department of Neurology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands
| | - Durk-Jouke van der Zee
- Department of Operations, Faculty of Economics and Business, University of Groningen, Groningen, the Netherlands
- Department of Epidemiology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands
| | - Maarten Uyttenboogaart
- Department of Neurology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands
- Department of Radiology, Medical Imaging Center, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands
| | - Erik Buskens
- Department of Operations, Faculty of Economics and Business, University of Groningen, Groningen, the Netherlands
- Department of Epidemiology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands
| | - Maarten M H Lahr
- Department of Epidemiology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands
| |
Collapse
|
5
|
Parikh NS, Chatterjee A, Díaz I, Pandya A, Merkler AE, Gialdini G, Kummer BR, Mir SA, Lerario MP, Fink ME, Navi BB, Kamel H. Modeling the Impact of Interhospital Transfer Network Design on Stroke Outcomes in a Large City. Stroke 2018; 49:370-376. [PMID: 29343588 DOI: 10.1161/strokeaha.117.018166] [Citation(s) in RCA: 13] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/23/2017] [Revised: 12/07/2017] [Accepted: 12/11/2017] [Indexed: 11/16/2022]
Abstract
BACKGROUND AND PURPOSE We sought to model the effects of interhospital transfer network design on endovascular therapy eligibility and clinical outcomes of stroke because of large-vessel occlusion for the residents of a large city. METHODS We modeled 3 transfer network designs for New York City. In model A, patients were transferred from spoke hospitals to the closest hub hospitals with endovascular capabilities irrespective of hospital affiliation. In model B, which was considered the base case, patients were transferred to the closest affiliated hub hospitals. In model C, patients were transferred to the closest affiliated hospitals, and transfer times were adjusted to reflect full implementation of streamlined transfer protocols. Using Monte Carlo methods, we simulated the distributions of endovascular therapy eligibility and good functional outcomes (modified Rankin Scale score, 0-2) in these models. RESULTS In our models, 200 patients (interquartile range [IQR], 168-227) with a stroke amenable to endovascular therapy present to New York City spoke hospitals each year. Transferring patients to the closest hub hospital irrespective of affiliation (model A) resulted in 4 (IQR, 1-9) additional patients being eligible for endovascular therapy and an additional 1 (IQR, 0-2) patient achieving functional independence. Transferring patients only to affiliated hospitals while simulating full implementation of streamlined transfer protocols (model C) resulted in 17 (IQR, 3-41) additional patients being eligible for endovascular therapy and 3 (IQR, 1-8) additional patients achieving functional independence. CONCLUSIONS Optimizing acute stroke transfer networks resulted in clinically small changes in population-level stroke outcomes in a dense, urban area.
Collapse
Affiliation(s)
- Neal S Parikh
- From the Clinical and Translational Neuroscience Unit, Feil Family Brain and Mind Research Institute, New York, NY (N.S.P., A.C., A.E.M., G.G., B.R.K., S.A.M., M.P.L., M.E.F., B.B.N., H.K.); Department of Neurology (N.S.P., A.E.M., S.A.M., M.E.F., B.B.N., H.K.) and Department of Healthcare Policy and Research (I.D.), Weill Cornell Medicine, New York, NY; Center for Health Decision Science, Harvard T.H. Chan School of Public Health, Boston, MA (A.P.); Department of Biomedical Informatics, Columbia University, New York, NY (B.R.K.); and Department of Neurology, NewYork-Presbyterian Queens, Flushing (M.P.L.).
| | - Abhinaba Chatterjee
- From the Clinical and Translational Neuroscience Unit, Feil Family Brain and Mind Research Institute, New York, NY (N.S.P., A.C., A.E.M., G.G., B.R.K., S.A.M., M.P.L., M.E.F., B.B.N., H.K.); Department of Neurology (N.S.P., A.E.M., S.A.M., M.E.F., B.B.N., H.K.) and Department of Healthcare Policy and Research (I.D.), Weill Cornell Medicine, New York, NY; Center for Health Decision Science, Harvard T.H. Chan School of Public Health, Boston, MA (A.P.); Department of Biomedical Informatics, Columbia University, New York, NY (B.R.K.); and Department of Neurology, NewYork-Presbyterian Queens, Flushing (M.P.L.)
| | - Iván Díaz
- From the Clinical and Translational Neuroscience Unit, Feil Family Brain and Mind Research Institute, New York, NY (N.S.P., A.C., A.E.M., G.G., B.R.K., S.A.M., M.P.L., M.E.F., B.B.N., H.K.); Department of Neurology (N.S.P., A.E.M., S.A.M., M.E.F., B.B.N., H.K.) and Department of Healthcare Policy and Research (I.D.), Weill Cornell Medicine, New York, NY; Center for Health Decision Science, Harvard T.H. Chan School of Public Health, Boston, MA (A.P.); Department of Biomedical Informatics, Columbia University, New York, NY (B.R.K.); and Department of Neurology, NewYork-Presbyterian Queens, Flushing (M.P.L.)
| | - Ankur Pandya
- From the Clinical and Translational Neuroscience Unit, Feil Family Brain and Mind Research Institute, New York, NY (N.S.P., A.C., A.E.M., G.G., B.R.K., S.A.M., M.P.L., M.E.F., B.B.N., H.K.); Department of Neurology (N.S.P., A.E.M., S.A.M., M.E.F., B.B.N., H.K.) and Department of Healthcare Policy and Research (I.D.), Weill Cornell Medicine, New York, NY; Center for Health Decision Science, Harvard T.H. Chan School of Public Health, Boston, MA (A.P.); Department of Biomedical Informatics, Columbia University, New York, NY (B.R.K.); and Department of Neurology, NewYork-Presbyterian Queens, Flushing (M.P.L.)
| | - Alexander E Merkler
- From the Clinical and Translational Neuroscience Unit, Feil Family Brain and Mind Research Institute, New York, NY (N.S.P., A.C., A.E.M., G.G., B.R.K., S.A.M., M.P.L., M.E.F., B.B.N., H.K.); Department of Neurology (N.S.P., A.E.M., S.A.M., M.E.F., B.B.N., H.K.) and Department of Healthcare Policy and Research (I.D.), Weill Cornell Medicine, New York, NY; Center for Health Decision Science, Harvard T.H. Chan School of Public Health, Boston, MA (A.P.); Department of Biomedical Informatics, Columbia University, New York, NY (B.R.K.); and Department of Neurology, NewYork-Presbyterian Queens, Flushing (M.P.L.)
| | - Gino Gialdini
- From the Clinical and Translational Neuroscience Unit, Feil Family Brain and Mind Research Institute, New York, NY (N.S.P., A.C., A.E.M., G.G., B.R.K., S.A.M., M.P.L., M.E.F., B.B.N., H.K.); Department of Neurology (N.S.P., A.E.M., S.A.M., M.E.F., B.B.N., H.K.) and Department of Healthcare Policy and Research (I.D.), Weill Cornell Medicine, New York, NY; Center for Health Decision Science, Harvard T.H. Chan School of Public Health, Boston, MA (A.P.); Department of Biomedical Informatics, Columbia University, New York, NY (B.R.K.); and Department of Neurology, NewYork-Presbyterian Queens, Flushing (M.P.L.)
| | - Benjamin R Kummer
- From the Clinical and Translational Neuroscience Unit, Feil Family Brain and Mind Research Institute, New York, NY (N.S.P., A.C., A.E.M., G.G., B.R.K., S.A.M., M.P.L., M.E.F., B.B.N., H.K.); Department of Neurology (N.S.P., A.E.M., S.A.M., M.E.F., B.B.N., H.K.) and Department of Healthcare Policy and Research (I.D.), Weill Cornell Medicine, New York, NY; Center for Health Decision Science, Harvard T.H. Chan School of Public Health, Boston, MA (A.P.); Department of Biomedical Informatics, Columbia University, New York, NY (B.R.K.); and Department of Neurology, NewYork-Presbyterian Queens, Flushing (M.P.L.)
| | - Saad A Mir
- From the Clinical and Translational Neuroscience Unit, Feil Family Brain and Mind Research Institute, New York, NY (N.S.P., A.C., A.E.M., G.G., B.R.K., S.A.M., M.P.L., M.E.F., B.B.N., H.K.); Department of Neurology (N.S.P., A.E.M., S.A.M., M.E.F., B.B.N., H.K.) and Department of Healthcare Policy and Research (I.D.), Weill Cornell Medicine, New York, NY; Center for Health Decision Science, Harvard T.H. Chan School of Public Health, Boston, MA (A.P.); Department of Biomedical Informatics, Columbia University, New York, NY (B.R.K.); and Department of Neurology, NewYork-Presbyterian Queens, Flushing (M.P.L.)
| | - Michael P Lerario
- From the Clinical and Translational Neuroscience Unit, Feil Family Brain and Mind Research Institute, New York, NY (N.S.P., A.C., A.E.M., G.G., B.R.K., S.A.M., M.P.L., M.E.F., B.B.N., H.K.); Department of Neurology (N.S.P., A.E.M., S.A.M., M.E.F., B.B.N., H.K.) and Department of Healthcare Policy and Research (I.D.), Weill Cornell Medicine, New York, NY; Center for Health Decision Science, Harvard T.H. Chan School of Public Health, Boston, MA (A.P.); Department of Biomedical Informatics, Columbia University, New York, NY (B.R.K.); and Department of Neurology, NewYork-Presbyterian Queens, Flushing (M.P.L.)
| | - Matthew E Fink
- From the Clinical and Translational Neuroscience Unit, Feil Family Brain and Mind Research Institute, New York, NY (N.S.P., A.C., A.E.M., G.G., B.R.K., S.A.M., M.P.L., M.E.F., B.B.N., H.K.); Department of Neurology (N.S.P., A.E.M., S.A.M., M.E.F., B.B.N., H.K.) and Department of Healthcare Policy and Research (I.D.), Weill Cornell Medicine, New York, NY; Center for Health Decision Science, Harvard T.H. Chan School of Public Health, Boston, MA (A.P.); Department of Biomedical Informatics, Columbia University, New York, NY (B.R.K.); and Department of Neurology, NewYork-Presbyterian Queens, Flushing (M.P.L.)
| | - Babak B Navi
- From the Clinical and Translational Neuroscience Unit, Feil Family Brain and Mind Research Institute, New York, NY (N.S.P., A.C., A.E.M., G.G., B.R.K., S.A.M., M.P.L., M.E.F., B.B.N., H.K.); Department of Neurology (N.S.P., A.E.M., S.A.M., M.E.F., B.B.N., H.K.) and Department of Healthcare Policy and Research (I.D.), Weill Cornell Medicine, New York, NY; Center for Health Decision Science, Harvard T.H. Chan School of Public Health, Boston, MA (A.P.); Department of Biomedical Informatics, Columbia University, New York, NY (B.R.K.); and Department of Neurology, NewYork-Presbyterian Queens, Flushing (M.P.L.)
| | - Hooman Kamel
- From the Clinical and Translational Neuroscience Unit, Feil Family Brain and Mind Research Institute, New York, NY (N.S.P., A.C., A.E.M., G.G., B.R.K., S.A.M., M.P.L., M.E.F., B.B.N., H.K.); Department of Neurology (N.S.P., A.E.M., S.A.M., M.E.F., B.B.N., H.K.) and Department of Healthcare Policy and Research (I.D.), Weill Cornell Medicine, New York, NY; Center for Health Decision Science, Harvard T.H. Chan School of Public Health, Boston, MA (A.P.); Department of Biomedical Informatics, Columbia University, New York, NY (B.R.K.); and Department of Neurology, NewYork-Presbyterian Queens, Flushing (M.P.L.)
| |
Collapse
|